Pediatric Infectious Disease Journal:


Free Access
Back to Top | Article Outline

Erratum to “Comparison of immunogenicity and tolerability of a vaccine-adjuvanted and a split influenza vaccine in children.” G. Kanra et al.

Pediatr Infect Dis J. 2004;23:300–306.

On page 300, in the Abstract under Results, lines 4, 9, 12, and 17, H3N2 should read H1N1, and H1N1 should read H3N2.

On page 304, in Table 2, under the “Treatment” column, 2 entries, “Virosome-adjuvanted” and “Split,” were inadvertently run together as one entry, with resulting misalignment of the values in the succeeding columns. The corrected Table 2 reads:

Table 2
Table 2
Image Tools

Cited By:

This article has been cited 2 time(s).

Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy
Esposito, S; Cecinati, V; Scicchitano, B; Delvecchio, GC; Santoro, N; Amato, D; Pelucchi, C; Jankovic, M; De Mattia, D; Principi, N
Vaccine, 28(6): 1558-1565.
Expert Opinion on Biological Therapy
The virosomal adjuvanted influenza vaccine
Calcagnile, S; Zuccotti, GV
Expert Opinion on Biological Therapy, 10(2): 191-200.
Back to Top | Article Outline

© 2004 Lippincott Williams & Wilkins, Inc.


Article Level Metrics